New and better information for scientists, toward novel therapeutic strategies in cancer and congenital disorders. We design, we produce and we provide research tools for gene expression analysis at the ribosomal level
We are engaged with customers at every step of the way.
The team leading IMMAGINA is composed by an experienced group of scientists, and c-level professionals, offering a mix of competencies that range from molecular biology, chemistry, nanotechnology, technology transfer, marketing, and business development. Among them, members of TBA (http://t-ba.eu/), BAN-TN (http://www.iban.it/it/mappa-dei-ban) and I.E.C.T. (the Hermann Hauser - Institute for Entrepreneurship, http://www.iect.at/homepage/).
The achievement of the many ambitious goals is sustained by the already accomplished R&D activities funded by both private and public stakeholders.
IMMAGINA relies on a series of partnerships already established to help business and market development.
We deliver high-quality solutions to assess translational control of gene expression and translatome-associated biomarkers.
The Ribosome Company
IMMAGINA designed, developed and commercialize a Platform Technology focused on Ribosome to isolate and analyse active ribosomes and the associated RNA molecules
IMMAGINA ambition is to deliver smart solutions for truer gene expression analysis in research and pharma labs, to support life science worldwide.
We are working to provide you with the best picture of gene expression. Because the message is only part of the story.
Wants to join the startup company to help accomplish our mission?
We are looking for a highly motivated Computational biologist to work on RNA-seq data
Please send Curriculum vitae, a letter describing your interest and contact details of three references to email@example.com. We will contact you if a new position will be open.
Active Ribosome Profiling with RiboLace – 2018
Ribolace: A novel method based on an innovative puromycin analogue capable of isolating ribosome in active translation.
[cit] Whole brain delivery of an instability-prone Mecp2 transgene improves behavioral and molecular pathological defects in mouse models of Rett syndrome – 2019
Global brain transduction of the instability-prone Mecp2 transgene by systemic AAV-PHP.eB administration is both safe and effective in protecting male and female Mecp2 mutant mice from the RTT disease phenotype
[cit] Recent advances in ribosome profiling for deciphering translational regulation – 2019
Ribosome profiling enables codon resolution analysis of mRNA translation.
New methods based on ribosome profiling provide novel insights into translational control.
Many tools are developed to facilitate the analysis of ribosome profiling data.